Funding news
Datavant logo

Datavant Secures $40M Series B

Recently funded · $40.0M Series bHospitals and Health CareUS

Get the full Datavant company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Datavant, the data collaboration platform trusted for healthcare, has secured $40.0 million in new investment capital. The company operates with a mission to make the world’s health data secure, accessible, and actionable, addressing a critical need within the global healthcare ecosystem.

The platform facilitates secure data exchange and collaboration among a diverse range of clients, including payers, providers, life sciences organizations, and legal and insurance entities worldwide. Datavant's technology is crucial for enabling the secure movement of over 60 million healthcare records between thousands of organizations, ensuring privacy while unlocking valuable insights. Its extensive network encompasses more than 80,000 hospitals and clinics, serves 75% of the 100 largest health systems, and integrates with over 350 real-world data partners. This broad reach underscores its pivotal role in accelerating research, improving patient care, and fostering innovation across the healthcare landscape by making complex health data actionable.

This funding round is intended to support Datavant's strategic growth initiatives and ongoing platform development. The company plans to deploy the capital to further enhance its secure data collaboration platform, expand its market presence across key healthcare segments, and continue its efforts to connect the fragmented health data ecosystem more effectively. The investment is expected to strengthen Datavant's capacity to meet the evolving demands for secure and actionable health data, reinforcing its commitment to improving healthcare outcomes through robust and ethical data collaboration.

Other United States companies recently funded

View all

Other recent Series b rounds

Companies that recently closed a Series b round.

#CompanyAmount
1
Innefu Labs logo

Innefu Labs

India

$30.0M
2
Fuse Energy logo

Fuse Energy

United Kingdom

$30.0M
3
ONA Therapeutics logo

ONA Therapeutics

Spain

$86.6M
4
GR3N SA logo

GR3N SA

Switzerland

$15.5M
5
701x logo

701x

United States

$10.0M